Marks Lianne, Altman Norman H, Podack Eckhard R, Levy Robert B
Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33101, USA.
Transplantation. 2004 Mar 27;77(6):804-12. doi: 10.1097/01.tp.0000110416.96307.d5.
Graft-versus-host disease (GvHD) is a frequent impediment to therapeutically successful allogeneic bone-marrow transplantation (BMT). This investigation further examines the roles of two potential donor cytotoxic effector mechanisms previously implicated in tissue pathogenesis. Cytotoxically double deficient (B6-cdd) T cells (lacking functional fas ligand and perforin) and wild-type (B6-wt) donor T-cell transplantation in a minor antigen-mismatched BMT model (C57BL/6 --> C3H.SW) resulted in similar mortality and weight loss. Histopathologic findings revealed mononuclear infiltrates and cellular atrophy in GvHD target tissues (liver, stomach) in recipients of B6-wt and B6-cdd donor T cells. Both recipients also exhibited GvH-associated lymphohematopoietic compartment (LHC) alterations as evidenced by inverted CD4:CD8 ratios and B-cell hypoplasia. Notably, transplants using recombinant inbred mHAg disparate recipients demonstrated that B6-cdd T cells induced lethal GvHD in CXBE but not CXBG recipients: the same pattern induced by B6-wt T cells. This observation is consistent with previous findings that cytotoxic T lymphocyte (CTL) responses against CXBG and CXBE antigens did not correlate with GvH responses in these strains. In contrast with the typical pattern of donor T-cell expansion and contraction, T cells lacking perforin and FasL function exhibited extensive expansion postBMT. In summary, these findings support the notion that donor anti-host cytotoxicity by way of the two major pathways is not a prerequisite for induction of GvHD. In addition, the results suggest that this model will be useful to investigate the regulation of allogeneic donor T-cell expansion after major histocompatibility complex-matched allogeneic BMT.
移植物抗宿主病(GvHD)是治疗成功的异基因骨髓移植(BMT)的常见障碍。本研究进一步探讨了两种先前与组织发病机制有关的潜在供体细胞毒性效应机制的作用。在一个次要抗原不匹配的BMT模型(C57BL/6→C3H.SW)中,细胞毒性双缺陷(B6-cdd)T细胞(缺乏功能性Fas配体和穿孔素)和野生型(B6-wt)供体T细胞移植导致了相似的死亡率和体重减轻。组织病理学结果显示,B6-wt和B6-cdd供体T细胞受体的GvHD靶组织(肝脏、胃)中有单核细胞浸润和细胞萎缩。两个受体还表现出与移植物抗宿主相关的淋巴造血区室(LHC)改变,表现为CD4:CD8比值倒置和B细胞发育不全。值得注意的是,使用重组近交mHAg不同受体的移植表明,B6-cdd T细胞在CXBE受体而非CXBG受体中诱导了致命的GvHD:这与B6-wt T细胞诱导的模式相同。这一观察结果与先前的发现一致,即在这些品系中,针对CXBG和CXBE抗原的细胞毒性T淋巴细胞(CTL)反应与移植物抗宿主反应不相关。与供体T细胞典型的扩增和收缩模式相反,缺乏穿孔素和FasL功能的T细胞在骨髓移植后表现出广泛的扩增。总之,这些发现支持了这样一种观点,即通过两条主要途径的供体抗宿主细胞毒性不是诱导GvHD的先决条件。此外,结果表明该模型将有助于研究主要组织相容性复合体匹配的异基因骨髓移植后异基因供体T细胞扩增的调节。